Venture Capital · Herzeliya (Israel) · Founded 2004
Pontifax is a healthcare-dedicated venture capital firm with over $1.2 billion under management. They invest in transformative life sciences technologies at all development stages, focusing on breakthrough innovations. Pontifax takes a hands-on approach, actively participating in the strategic direction of its portfolio companies.
Series A, Series B
BioTech, Digital Health, MedTech
Abcur, Adicet Bio, AgomAb Therapeutics, Allena Pharmaceuticals, ArQule, CathWorks, cCAM Biotherapeutics, Check-Cap, CytoReason, Dynacure, Eloxx Pharmaceuticals, Enlivex Therapeutics, Eyevensys, EyeYon, ForSight VISION6 Inc, Genocea, Horama, IMEL Biotherapeutics, Immunic Therapeutics, Kamari Pharma, Keros, Kite Pharma, Levation, LogicBio, Lutris Pharma, Mereo BioPharma, Metabomed, NovellusDx, OCON Medical, Opiant, PACT Pharma, Pi Therapeutics, Precirix, Prevail Therapeutics, ProQR, Raziel Therapeutics, ReWalk, RyCarma Therapeutics, Saniona, Silverback Therapeutics, Soligenix, Stargazer Pharmaceuticals, Step Pharma, Stimatix, Stride Bio, Sweetch, TargEDys, UroGen, V-Wave, Vanqua Bio, Vascular Graft Solutions, VBI Vaccines